[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345624-105":59,"doc-detail-345624-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","profiling-the-tumor-immunological-status-in-japanese-solid-cancers-using-the-tumor-immune-status-scoring-algorithm","Profiling the tumor immunological status in Japanese solid cancers using the tumor immune status scoring algorithm","","Immune-score approaches to quantify tumor microenvironment (TME) status and predict immune checkpoint blockade efficacy often rely on complex gene signatures. To enable faster, numerical evaluation across large cohorts, this study calculates tumor immune status scoring algorithm (TIMMUSCORA) scores from expression data of 300 immune response-associated genes in 5,013 pancancer patients, then tests associations with prognosis and clinicopathological features. In rectal cancer, higher TIMMUSCORA scores above a cut-off correlate with favorable outcomes and immune response genes including PDCD1, GZMB, TNFRSF10C, EBI3, and IRF1. Correlation analysis shows high scores align with high TMB and CMS1, whereas low scores align with WNT gene expression, supporting TIMMUSCORA’s utility for TME immune profiling and solid cancer prognosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/profiling-the-tumor-immunological-status-in-japanese-solid-cancers-using-the-tumor-immune-status-scoring-algorithm/345624/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/profiling-the-tumor-immunological-status-in-japanese-solid-cancers-using-the-tumor-immune-status-scoring-algorithm/345624.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does TIMMUSCORA address compared with immunological gene signatures?","Question",{"text":112,"@type":113},"Immunological gene signatures are complex and time-consuming. TIMMUSCORA provides a simpler scoring system using numerical expression data to evaluate many tumors more efficiently.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are TIMMUSCORA scores calculated?",{"text":117,"@type":113},"The expression of 300 immune response-associated genes is scored from 1 to 4. Scores for down-regulated genes are subtracted from scores for up-regulated genes based on fold-change criteria, producing the final TIMMUSCORA score.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical relationship is observed in rectal cancer for high TIMMUSCORA scores?",{"text":121,"@type":113},"Rectal cancers with TIMMUSCORA scores higher than a specified cut-off show a good prognosis, closely associated with immune response-associated genes such as PDCD1, GZMB, TNFRSF10C, EBI3, and IRF1.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345624,1790178541,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nProfiling the tumor immunological status in Japanese solid cancers using the tumor immune status scoring algorithm  \nTomoatsu Ikeya1,14, Yasufumi Kikuchi1,14, Tadashi Ashizawa1, Akari Kanematsu1, Chie Maeda1, Akira Iizuka1, Kazue Yamashita1, Haruo Miyata1, Takeshi Nagashima2,13, Kenichi Urakami2, Yuji Shimoda2, Keiichi Ohshima3, Koji Muramatsu5, Takashi Sugino5, Akio Shiomi6, Yasuhisa Ohde7, Etsuro Bando8, Teiichi Sugiura9, Takashi Mukaigawa10, Seiichiro Nishimura11, Hirotsugu Kenmotsu12, Ken Yamaguchi4 & YasutoAkiyama1􀀍  \nIn the last decade, methods to investigate the immune status of the tumor microenvironment (TME) and predict immune checkpoint blockade efficacy have been intensively developed as immunoscores or immune signatures. However, since the immunological gene signature is a complex and timeconsuming approach, a simpler scoring system using numerical data is needed to evaluate a large number of tumors. We previously established aTME immune-type classification system based on PD-L1 and CD8B gene expression, and 5032 cancer patients were classified into 4 types. Based on the expression levels of immune response-associated genes in each type, these genes were assigned scores ranging 1 to 4, representing a spectrum from immunosuppressiveto immunostimulating genes. We herein calculated tumor immune status scoring algorithm (TIMMUSCORA) scores based on the expression data of 300 immune response-associated genes in 5,013 pancancer patients, and investigated the relationship of these scores with the prognosis and other clinicopathological features of cancer patients. Rectal cancers with higher scores than the cut-off value of 0 showed a good prognosis, which was closely associated with the immune response-associated genes PDCD1, GZMB, TNFRSF10C, EBI3, and IRF1. A correlation analysis of the rectal cancer cohort suggested that high TIMMUSCORA scores correlated with high TMB value and the consensus molecular subtyping 1 status, while low scores correlated with WNT gene expression. Therefore, the TIMMUSCORA system has potential in evaluations ofthe immune status oftheTME and the prognosis of solid cancers.  \nKeywords Tumor microenvironment, Whole exome sequencing, Immune status scoring, Immune responseassociated genes, Overall survival  \nAbbreviations  \nTMEWES GEPTILTMB  \nTumor microenvironment Whole exome sequencing Gene expression profiling Tumor-infiltrating lymphocyte Tumor mutation burden  \n1Immunotherapy Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan. 2Cancer Diagnostic Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan. 3Medical Genetics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.  \n4Office of the President Emeritus, Shizuoka Cancer Center, Shizuoka, Japan. 5Division of Pathology, Shizuoka Cancer Center Hospital, Shizuoka, Japan. 6Division of Colon and Rectal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan. 7Division of Thoracic Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan. 8Division of Gastric Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan. 9Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan. 10Division of Head and Neck Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan. 11Division of Breast Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan. 12Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan. 13SRL Inc, Tokyo, Japan. 14Tomoatsu Ikeya andYasufumi Kikuchi contributed equally to this work. 􀀍 [email: y.akiyama@scchr.jp](email: y.akiyama@scchr.jp)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nPD-L1 Programmed death-ligand 1  \nTIMMUSCORA Tumor immune status scoring algorithm  \nCMS Consensus molecular subtyping  \nIn the last decade, researchers have investigated the ","cbCaitLQSZTWcDTP","https://ap.wps.com/l/cbCaitLQSZTWcDTP","pdf",1908738,"English","# Introduction\n## Existing immunoscores and biomarkers\n## Need for simpler numerical scoring systems\n# Methods\n## TIMMUSCORA scoring framework\n## Patient cohorts and gene expression basis\n# Results\n## Rectal cancer prognosis and key immune genes\n## Associations with TMB and CMS1\n## Associations with WNT signaling\n# Discussion\n## Potential applications for immune profiling and prognosis","[{\"question\":\"What problem does TIMMUSCORA address compared with immunological gene signatures?\",\"answer\":\"Immunological gene signatures are complex and time-consuming. TIMMUSCORA provides a simpler scoring system using numerical expression data to evaluate many tumors more efficiently.\"},{\"question\":\"How are TIMMUSCORA scores calculated?\",\"answer\":\"The expression of 300 immune response-associated genes is scored from 1 to 4. Scores for down-regulated genes are subtracted from scores for up-regulated genes based on fold-change criteria, producing the final TIMMUSCORA score.\"},{\"question\":\"What clinical relationship is observed in rectal cancer for high TIMMUSCORA scores?\",\"answer\":\"Rectal cancers with TIMMUSCORA scores higher than a specified cut-off show a good prognosis, closely associated with immune response-associated genes such as PDCD1, GZMB, TNFRSF10C, EBI3, and IRF1.\"}]","Profiling the tumor immunological status in Japanese solid cancers using the tumor immune status scoring algorithm | PDF",1790058360,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ba4c3defb214f9fce38a44e49a55d29.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d82b0a9833dfa2cb13d69a6fa89dc103.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30ef29a91c71b0f031df57bb7209758d.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef9b4d42154614139a31b2a9276bb29f.webp",980,1287]